Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APIC: Maintenance vs Intermittent Antipsychotics in Schizophrenia
NCT02435095Phase 4Terminated
- Sponsor
- RWTH Aachen University
- Start
- May 2015
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in schizophrenia (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Total grey matter volume at 12 months. Started May 2015; status: terminated.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02435095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435095.